STAAR SURGICAL CO (STAA) earnings date, results and what the price requires
Nasdaq · SEC CIK 0000718937 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jul 3, 2026 | Aug 12, 2026 | $93.5M | $8.1M | $0.16 | Filing |
| Apr 3, 2026 | May 13, 2026 | $93.5M | $5.2M | $0.10 | Filing |
| Jan 2, 2026 | Mar 3, 2026 | $57.8M | $-18.3M | $-0.36 | Filing |
| Sep 26, 2025 | Oct 20, 2025 | $94.7M | $8.9M | $0.18 | Filing |
| Jun 27, 2025 | Aug 6, 2025 | $44.3M | $-16.8M | $-0.34 | Filing |
| Mar 28, 2025 | May 7, 2025 | $42.6M | $-54.2M | $-1.10 | Filing |
| Dec 27, 2024 | Feb 11, 2025 | $49.0M | $-34.2M | $-0.69 | Filing |
| Sep 27, 2024 | Oct 30, 2024 | $88.6M | $10.0M | $0.20 | Filing |
What would STAAR SURGICAL CO have to report for its valuation to change?
At $21.27, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 86.8% a year, to $1.82. On that path the next quarter needs diluted EPS near $0.34, against $0.18 in the quarter ended Sep 26, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 86.8% | 86.8% |
| EPS needed in final year | $1.82 | $1.82 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. STAA goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.